Provided by Tiger Trade Technology Pte. Ltd.

Amgen

439.33
+8.121.88%
Post-market: 439.05-0.2800-0.06%19:56 EDT
Volume:2.11M
Turnover:926.13M
Market Cap:236.57B
PE:27.29
High:440.51
Open:431.72
Low:429.38
Close:431.21
52wk High:443.20
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.82
T/O Rate:0.39%
Dividend:9.80
Dividend Rate:2.23%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:20.24
PE(LYR):30.87

Loading ...

Sino Biopharmaceutical Stock Advances 3.8% in Hong Kong

Dow Jones
·
Jul 20

Coca-cola, IBM Share Losses Contribute to Dow's Nearly 300-point Drop

Dow Jones
·
Jul 18

Amgen Halts Bemarituzumab Gastric Cancer Trial, Shifting Oncology Expectations

TIPRANKS
·
Jul 18

Sino Biopharmaceutical Stock Slips 5.3% in Hong Kong

Dow Jones
·
Jul 17

Movement Alert|Amgen Rises 3.07% in Pre-Market Trading, Multiple Investment Banks Raise Target Prices Amid Sector Strength

Market Focus
·
Jul 17

Movement Alert|Amgen Rises 3.07% Overnight, Multiple Investment Banks Raise Price Targets Amid Sector Strength

Market Focus
·
Jul 17

Amgen Inc Stock (AMGN) Closed Up by 3.70% on Jul 16: Drivers Behind the Movement

TradingKey
·
Jul 17

Gyre Therapeutics Adds CSO Yue Xiong, Max Kirkby, Claire Weston to Board Effective Aug. 1

Reuters
·
Jul 17

Movement Alert|Amgen Rises 3.03% in Regular Trading, Multiple Investment Banks Raise Target Prices Amid Sector Strength

Market Focus
·
Jul 17

Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats

TIPRANKS
·
Jul 17

Amgen’s Rocatinlimab Eczema Trial Termination Jolts Investor Expectations

TIPRANKS
·
Jul 17

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

Reuters
·
Jul 16

Citi Sticks to Its Hold Rating for Amgen (AMGN)

TIPRANKS
·
Jul 16

Amgen Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 14

BofA Securities Adjusts Amgen Price Target to $312 From $307

MT Newswires Live
·
Jul 13

UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating

MT Newswires Live
·
Jul 13

Amgen Inc : UBS Raises Target Price to $420 from $400

THOMSON REUTERS
·
Jul 13

Cue Biopharma Names Dominic Borie Chief Medical Officer, Head of R&D

Reuters
·
Jul 13

Amgen is Maintained at Neutral by Guggenheim

Dow Jones
·
Jul 13